Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Amortizatization of Intangibles: 2020-2025

Historic Amortizatization of Intangibles for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to $7.2 million.

  • Maravai Lifesciences Holdings' Amortizatization of Intangibles rose 4.61% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.3 million, marking a year-over-year increase of 3.07%. This contributed to the annual value of $27.5 million for FY2024, which is 0.64% up from last year.
  • Maravai Lifesciences Holdings' Amortizatization of Intangibles amounted to $7.2 million in Q3 2025, which was up 0.12% from $7.2 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Amortizatization of Intangibles registered a high of $7.2 million during Q3 2025, and its lowest value of $3.7 million during Q4 2021.
  • Its 3-year average for Amortizatization of Intangibles is $6.9 million, with a median of $6.9 million in 2023.
  • In the last 5 years, Maravai Lifesciences Holdings' Amortizatization of Intangibles fell by 29.24% in 2021 and then soared by 70.66% in 2022.
  • Quarterly analysis of 5 years shows Maravai Lifesciences Holdings' Amortizatization of Intangibles stood at $3.7 million in 2021, then skyrocketed by 70.66% to $6.2 million in 2022, then rose by 10.15% to $6.9 million in 2023, then increased by 0.48% to $6.9 million in 2024, then rose by 4.61% to $7.2 million in 2025.
  • Its last three reported values are $7.2 million in Q3 2025, $7.2 million for Q2 2025, and $7.0 million during Q1 2025.